Cargando…

Coming together to improve access to medicines: The genesis of the East African Community’s Medicines Regulatory Harmonization initiative

Hiiti Sillo and colleagues reveal how the East African Community’s Medicines Regulatory Harmonization initiative improves access to important medicines in Africa.

Detalles Bibliográficos
Autores principales:	Sillo, Hiiti, Ambali, Aggrey, Azatyan, Samvel, Chamdimba, Chimwemwe, Kaale, Eliangiringa, Kabatende, Joseph, Lumpkin, Murray, Mashingia, Jane H., Mukanga, David, Nyabenda, Bonaventure, Sematiko, Gordon, Sigonda, Margareth, Simai, Burhani, Siyoi, Fred, Sonoiya, Stanley, Ward, Mike, Ahonkhai, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Collection Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423075/ https://www.ncbi.nlm.nih.gov/pubmed/32785273 http://dx.doi.org/10.1371/journal.pmed.1003133

Ejemplares similares

Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned
por: Mashingia, Jane H., et al.
Publicado: (2020)

Optimizing the East African Community’s Medicines Regulatory Harmonization initiative in 2020–2022: A Roadmap for the Future
por: Arik, Mawien, et al.
Publicado: (2020)

Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market
por: Sillo, Hiiti B., et al.
Publicado: (2018)

Medicines Regulation in Africa: Current State and Opportunities
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2017)

Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2023)

National medicines regulatory authorities financial sustainability in the East African Community
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2020)

Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority
por: Mori, Amani Thomas, et al.
Publicado: (2018)

Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2021)

The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania
por: Mori, Amani Thomas, et al.
Publicado: (2014)

Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD’s experience in establishing regulatory systems for medicines and GM crops in Africa
por: Glover, Barbara, et al.
Publicado: (2018)

The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania
por: Kaale, Eliangiringa, et al.
Publicado: (2016)

Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization
por: Ahonkhai, Vincent, et al.
Publicado: (2016)

Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward
por: Ngum, Nancy, et al.
Publicado: (2022)

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement
por: Ngum, Nancy, et al.
Publicado: (2022)

Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework
por: Mori, Amani Thomas, et al.
Publicado: (2012)

Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa
por: Keyter, Andrea, et al.
Publicado: (2020)

Accessing Occupational Health Services in the Southern African Development Community Region
por: Masekameni, Masilu Daniel, et al.
Publicado: (2020)

Reforms: a quest for efficiency or an opportunity for vested interests’? a case study of pharmaceutical policy reforms in Tanzania
por: Mori, Amani Thomas, et al.
Publicado: (2013)

A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania
por: Mwamwitwa, Kissa W., et al.
Publicado: (2020)

Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study
por: Mziray, Sophia, et al.
Publicado: (2021)

Formulation development of chewable albendazole tablets with improved dissolution rate
por: Kimaro, Emmanuel, et al.
Publicado: (2019)

Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs: experiences of the WHO and Swissmedic
por: Dehaghi, Razieh Ostad Ali, et al.
Publicado: (2023)

Worldwide Assessment of Low- and Middle-Income Countries' Regulatory Preparedness to Approve Medical Products During Public Health Emergencies
por: Khadem Broojerdi, Alireza, et al.
Publicado: (2021)

Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania
por: Mwamwitwa, Kissa W., et al.
Publicado: (2022)

Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design
por: Tibalinda, Prosper, et al.
Publicado: (2016)

The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage
por: Khadem Broojerdi, Alireza, et al.
Publicado: (2020)

A new approach to an old problem: Overview of the East African Community’s Medicines Regulatory Harmonization initiative
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2020)

National Antibiotics Utilization Trends for Human Use in Tanzania from 2010 to 2016 Inferred from Tanzania Medicines and Medical Devices Authority Importation Data
por: Sangeda, Raphael Zozimus, et al.
Publicado: (2021)

Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons
por: Hoellein, Ludwig, et al.
Publicado: (2022)

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
por: Roth, Lukas, et al.
Publicado: (2018)

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost
por: Costa, Enrico, et al.
Publicado: (2020)

Erratum to: Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study
por: Rutta, Edmund, et al.
Publicado: (2015)

Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study
por: Rutta, Edmund, et al.
Publicado: (2015)

Modeling solutions to Tanzania's physician workforce challenge
por: Goodell, Alex J., et al.
Publicado: (2016)

Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021
por: Wande, Dickson Pius, et al.
Publicado: (2019)

An overview of Internal Medicine Point-of-Care Ultrasound rotations in Canada
por: Gaudreau-Simard, Mathilde, et al.
Publicado: (2022)

Involvement of Local Communities and Households in the Implementation of the “One Health” Initiative Through the East African Integrated Disease Surveillance Network (EAIDSNet)
por: SONOIYA, Stanley S.
Publicado: (2015)

Correction: An overview of internal medicine point-of-care ultrasound rotations in Canada
por: Gaudreau-Simard, Mathilde, et al.
Publicado: (2022)

Use of traditional medicine for the treatment of diabetes in Eastern Uganda: a qualitative exploration of reasons for choice
por: Rutebemberwa, Elizeus, et al.
Publicado: (2013)

Attitudes Underlying Reliance on Complementary and Alternative Medicine
por: Zörgő, Szilvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_laoip29985vrecbh5jnirkripd